MedPath
NMPA Approval

Acalabrutinib Maleate Tablets

国药准字HJ20240118

October 29, 2024

Drug Information

马来酸阿可替尼片

片剂

100mg(按C₂₆H₂₃N₇O₂计)

化学药品

October 29, 2024

October 28, 2029

Company Information

Applicant Company

66 Talavera Road Macquarie Park NSW 2113 AUSTRALIA

Manufacturing Company

ASTRAZENECA AB

Gartunavagen Sodertalje S-15257 Sweden

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

马来酸阿可替尼片 - NMPA 批准文号 | MedPath